| 标题： | 绝经后骨质疏松症中西医结合诊疗指南 |
| title： | Diagnosis and Treatment of Post-Menopausal Osteoporosis with Integrating Traditional Chinese Medicine and Western Medicine |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 中医药指南 |
| classification： | Traditional Chinese Medicine guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本文件适用于中医院、中西医结合医院的中医骨伤科、骨质疏松专科、内分泌科、康复科、老年病科、风湿科、妇科相关医师的临床诊治。 |
| Guide users： | This document is applicable to the clinical diagnosis and treatment of TCM orthopaedics, osteoporosis, endocrinology, rehabilitation, geriatrics, rheumatology and gynecology in hospitals of traditional Chinese medicine and integrated Chinese and Western medicine. |
| 证据分级方法： | 对不同类型的研究选用不同的证据质量评价工具进行评价。使用 系统评价偏倚风险评价工具2（a measurement tool to assess systematic reviews 2， AMSTAR 2）对系统评价和Meta分析进行偏倚风险评价；使用Cochrane 偏倚风险评价工具 （risk of bias，ROB，针对随机对照试验）、纽卡斯尔-渥太华量表（Newcastle-Ottawa scale， NOS，针对队列研究和病例对照研究）和加拿大卫生经济研究所量表（institute of health economics，IHE，针对病例系列和病例报告）等评价工具分别对相应的原始研究进行方法学 质量评价。评价过程由2位证据评价组成员独立完成，如存在分歧，则通过共同讨论或咨询 第三方协商解决。 |
| Evidence grading method： | Different evidence quality evaluation tools were used to evaluate different types of studies. Use (a measurement tool to assess systematic reviews 2, (a measurement tool to assess systematic reviews 2, AMSTAR 2) Conduct bias risk assessment for systematic review and meta-analysis; The Cochrane bias risk assessment tool was used (risk of bias, ROB, for randomized controlled trials), Newcastle-Ottawa scale (Newcastle-Ottawa scale, NOS, for cohort and case-control studies) and the Canadian institute of health Economics Scale (institute of health Evaluation tools such as economics, IHE, for Case series, and Case reports were methodologically applied to the respective original studies Quality evaluation. The evaluation process is completed independently by two members of the evidence evaluation team, and in case of disagreement, through joint discussion or consultation The third party shall negotiate the settlement. |
| 制定单位： | 浙江中医药大学附属第二医院 |
| Formulating unit： | The Second Affiliated Hospital of Zhejiang Chinese Medical University |
| 注册时间： | 2024-04-13 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN530 |
| Registration number： | |
| 指南制订的目的： | 制定一份适合我国绝经后骨质疏松症人群完善的中西医结合诊疗指南，对于提高绝经后骨质疏松症的诊断和治疗水平，促进中老年女性的健康具有重要的实际意义。 |
| Purpose of the guideline： | It is of great practical significance to formulate a perfect diagnosis and treatment guide of Chinese and Western medicine for postmenopausal osteoporosis population in China to improve the diagnosis and treatment level of postmenopausal osteoporosis and promote the health of middle-aged and elderly women. |
